Covered recipient · General Payments record
MICHELLE N MONTALVO
Physician Assistants & Advanced Practice Nursing Providers Advanced Practice Midwife
General Payments · PY2021–2023
$615.55
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $256.23 | 16 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $57.37 | 4 |
| PFIZER INC. | $34.76 | 2 |
| Organon LLC | $31.72 | 2 |
| Daiichi Sankyo Inc. | $30.40 | 2 |
| Sumitomo Pharma America, Inc. | $20.54 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $19.82 | 1 |
| MAYNE PHARMA COMMERCIAL LLC | $17.90 | 1 |
| Exeltis, USA Inc. | $14.85 | 1 |
| Radius Health, Inc. | $14.50 | 1 |
| Evofem Biosciences, Inc. | $14.37 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.50 | 02/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006248343 | CMS |
| ABBVIE INC. | $12.91 | 04/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006248345 | CMS |
| ABBVIE INC. | $12.91 | 04/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006248349 | CMS |
| ABBVIE INC. | $15.05 | 05/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006248351 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $19.82 | 05/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1005653551 | CMS |
| Daiichi Sankyo Inc. | $14.40 | 02/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006397321 | CMS |
| Daiichi Sankyo Inc. | $16.00 | 03/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1006366684 | CMS |
| Evofem Biosciences, Inc. | $14.37 | 01/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 976107415 | CMS |
| Exeltis, USA Inc. | $14.85 | 02/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002144255 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $17.90 | 08/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060864197 | CMS |
| Organon LLC | $18.50 | 01/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1046969137 | CMS |
| Organon LLC | $13.22 | 06/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1046969127 | CMS |
| PFIZER INC. | $15.59 | 02/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049624673 | CMS |
| PFIZER INC. | $19.17 | 05/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050278135 | CMS |
| Radius Health, Inc. | $14.50 | 03/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1024732351 | CMS |
| Sumitomo Pharma America, Inc. | $20.54 | 03/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1031092981 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023
- Source files
- Dataset page · Bulk file · PY2021 , PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.